APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 177 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,695,033 | -46.7% | 71,180 | -58.2% | 0.41% | -41.8% |
| Q4 2022 | $8,808,954 | -0.5% | 170,353 | +31.5% | 0.70% | -6.3% |
| Q3 2022 | $8,850,000 | +0.3% | 129,577 | -33.6% | 0.75% | +0.5% |
| Q2 2022 | $8,824,000 | -21.5% | 195,126 | -11.8% | 0.75% | -15.3% |
| Q1 2022 | $11,242,000 | -43.9% | 221,251 | -47.8% | 0.88% | -31.0% |
| Q4 2021 | $20,031,000 | +194.0% | 423,676 | +104.9% | 1.28% | +202.4% |
| Q3 2021 | $6,814,000 | -72.7% | 206,746 | -47.7% | 0.42% | -66.6% |
| Q2 2021 | $24,966,000 | +53.4% | 395,033 | +4.1% | 1.27% | +17.2% |
| Q1 2021 | $16,280,000 | – | 379,395 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |